He Q - Search Results

1

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.

Song LX, Xu L, Li X, Chang CK, Zhang Y, Wu LY, He Q, Zhang QX, Li X. Song LX, et al. Among authors: he q. Ann Hematol. 2012 Dec;91(12):1879-86. doi: 10.1007/s00277-012-1550-y. Epub 2012 Aug 16. Ann Hematol. 2012. PMID: 22895556 Clinical Trial.

2

[Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia].

Qiu JY, Zhu W, Zhang Y, Chen SS, Jiang B, Shi HL, Shi Y, He Q, Dang H, Wang DB, Lu DP. Qiu JY, et al. Among authors: he q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Jun;13(3):358-63. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 15972120 Chinese.

3

[Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect].

He Q, Li X, Tao Y, Liu YZ, Yang LP, Ying SX. He Q, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Jun;13(3):483-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 15972147 Chinese.

4

Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes.

Li X, Wu L, Ying S, Chang C, He Q, Pu Q. Li X, et al. Among authors: he q. Leuk Lymphoma. 2007 Jul;48(7):1353-71. doi: 10.1080/10428190701395065. Leuk Lymphoma. 2007. PMID: 17613765

5

[Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].

Li X, Wu LY, Ying SX, Chang CK, He Q, Song LQ, Pu Q. Li X, et al. Among authors: he q. Zhonghua Xue Ye Xue Za Zhi. 2007 Jul;28(7):478-83. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18072633 Chinese.

6

[Biological behavior of stromal cell-derived factor-1 on migration, adhesion and apoptosis in different kinds of AML cell lines].

Chang CK, Li X, Wu LY, Xu L, Song LX, He Q, Ying SX, Deeg J. Chang CK, et al. Among authors: he q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):461-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18549608 Chinese.

7

Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.

Wu L, Li X, Chang C, Ying S, He Q, Pu Q. Wu L, et al. Among authors: he q. Int J Lab Hematol. 2008 Oct;30(5):390-9. doi: 10.1111/j.1751-553X.2007.00970.x. Int J Lab Hematol. 2008. PMID: 19046314

8

[Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].

Su JY, Chang CK, Zhang X, Zhou LY, Song LQ, Xu L, Wu LY, He Q, Li X. Su JY, et al. Among authors: he q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):459-63. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19379588 Clinical Trial. Chinese.

9

Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.

Wu L, Li X, Su J, Chang C, He Q, Zhang X, Xu L, Song L, Pu Q. Wu L, et al. Among authors: he q. Leuk Lymphoma. 2009 Sep;50(9):1461-7. doi: 10.1080/10428190903096719. Leuk Lymphoma. 2009. PMID: 19672772 Clinical Trial.

10

Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.

Xu F, Li X, Wu L, He Q, Zhang Z, Chang C. Xu F, et al. Among authors: he q. Br J Haematol. 2010 May;149(4):587-97. doi: 10.1111/j.1365-2141.2010.08146.x. Epub 2010 Mar 16. Br J Haematol. 2010. PMID: 20331463 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,853 results

Search Page

Filters